Requirement of a bone morphogenetic protein for the maintenance and stimulation of osteoblast differentiation

Archives of Histology and Cytology

Volumn 69, Issue 1, 2006, Pages 23-36

  Martinovic, Snjezana ^a   Borovecki, Fran ^a   Miljavac, Vera ^a   Kisic, Veronika ^a   Maticic, Drazen ^b   Francetic, Igor ^c   Vukicevic, Slobodan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b University of Zagreb Faculty of Veterinary Medicine   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; DEXAMETHASONE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CORRELATION ANALYSIS; CULTURE MEDIUM; ENDOCRINE FUNCTION; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PARACRINE SIGNALING; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; ESTRADIOL; GENE EXPRESSION REGULATION; MICE; OSTEOBLASTS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 33645800791     PISSN: 09149465     EISSN: 13491717     Source Type: Journal    
DOI: 10.1679/aohc.69.23     Document Type: Article

References (64)

1. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC: Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15: 663-673 (2000a).
2. Abe Y, Aida Y, Abe T, Hirofuji T, Anan H, Maeda K: Development of mineralized nodules in fetal rat mandibular osteogenic precursor cells: requirement for dexamethasone but not for β-glycerophosphate. Calcif Tissue Int 66: 66-69 (2000b).
3. Akiyama S, Katagiri T, Namiki M, Yamaji N, Yamamoto N, Miyama K, Shibuya H, Ueno N, Wozney JM, Suda T: Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp Cell Res 235: 362-369 (1997).
4. Asahina I, Sampath TK, Nishimura I, Hauschka PV: Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol 123: 921-933 (1993).
5. Asahina I, Sampath TK, Hauschka PV: Human osteogenic protein-1 induces chondroblastic, osteoblastic and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222: 38-47 (1996).
6. Bachner D, Ahrens M, Schroder D, Hoffmann A, Lauber J, Betat N, Steinert P, Flohe L, Gross G: Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn 213:398-411 (1998).
7. Balica M, Bostrom K, Shin V, Tillisch K, Demer LL: Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 95: 1954-1960 (1997).
8. Bellows CG, Aubin JE, Heersche JN: Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121: 1985-1992 (1987).
9. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ: PaTH Study Investigators. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207-1215 (2003).
10. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM, Nanes MS: Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137: 3401-3407 (1996).
11. Canalis E: Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 15: 454-457 (2003).
12. Chen TL, Fry D: Hormonal regulation of the osteoblastic phenotype expression in neonatal murine calvarial cells. Calcif Tissue Int 64: 304-309 (1999).
13. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE: Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60: 283-290 (1997).
14. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE: Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142: 295-305 (1998).
15. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV: Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286 (1994).
16. Cook SD, Rueger DC: Preclinical models of recombinant BMP induced healing of orthopedic defects. In: Bone morphogenetic proteins: from laboratory to clinical practice (Vukicevic S, Sampath TK, ed), Birkhauser Verlag, Basel-Boston-Berlin, 2002 (p.121-144).
17. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T: Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 12: 3519-27 (1999).
18. Einhorn TA: Clinical applications of recombinant human BMPs: early experience and future development. J Bone Joint Surg Am 85-A: 82-88 (2003).
19. Franceschi RT: The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 10: 40-57 (1999).
20. Franceschi RT, Iyer BS, Cui Y: Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 9: 843-854 (1994).
21. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A: S151-S158 (2001).
22. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K: Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10: 3801-3813 (1999).
23. Funaba M, Ogawa K, Abe M: Expression and localization of activin receptors during endochondral bone development. Eur J Endocrinol 144: 63-71 (2001).
24. Harris SE, Sabatini M, Harris MA, Feng JQ, Wozney J, Mundy GR: Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J Bone Miner Res 9: 389-394 (1994).
25. Harris SE, Feng JQ, Harris MA, Ghosh-Choudhury N, Dalls MR, Wozney JM, Mundy GR: Recombinant bone morphogenetic protein 2 accelerates bone cell differentiation and stimulates BMP-2 mRNA expression and BMP-2 promoter activity in primary fetal rat calvarial osteoblast cultures. Mol Cell Differ 3:137-155 (1995).
26. Hino J, Matsuo H, Kangawa K: Bone morphogenetic protein-3b (BMP-3b) gene expression is correlated with differentiation in rat calvarial osteoblasts. Biochem Biophys Res Commun 256: 419-424 (1999).
27. Honda Y, Knutsen R, Strong DD, Sampath TK, Baylink DJ, Mohan S: Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells. Calcif Tissue Int 60: 297-301 (1997).
28. Hughes FJ, Collyer J, Stanfield M, Goodman SA: The effects of bone morphogenetic protein-1, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 136: 2671-2677 (1995).
29. Ju W, Hoffmann A, Verschueren K, Tylzanowski P, Kaps C, Gross G, Huylebroeck D: The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res 15: 1889-1899 (2000).
30. Kaps C, Lauber J, Ju W, Czichos S, Gross G: The recombinant expression of bone morphogenetic protein type IA receptor (Alk3) in mesenchymal progenitors C3H10T1/2 is sufficient for osteo-/chondrogenic development. Biochem Soc Trans 26: 27-32 (1998).
31. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T: The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172: 295-299 (2002).
32. Kloen P, Di Paola M, Borens O, Richmond J, Perino G, Helfet DL, Goumans MJ: BMP signaling components are expressed in human fracture callus. Bone 33: 362-371 (2003).
33. Majeska RJ, Ryaby JT, Einhorn TA: Direct modulation of osteoblastic activity with estrogen. J Bone Joint Surg Am 76: 713-721 (1994).
34. Martinovic S, Borovecki F, Vukicevic S: Biology of the BMPs. In: Bone morphogenetic proteins: from laboratory to clinical practice (Vukicevic S, Sampath TK, ed), Birkhauser Verlag, Basel-Boston-Berlin, 2002 (p. 87-119).
35. Martinovic S, Borovecki F, Vukicevic S: Biology of bone morphogenetic proteins. In: Bone morphogenetic proteins: regeneration of bone and beyond (Vukicevic S, Sampath TK, ed), Birkhauser Verlag, Basel-Boston-Berlin, 2004 (p. 45-72).
36. Namiki M, Akiyama S, Katagiri T, Suzuki A, Ueno N, Yamaji N, Rosen V, Wozney JM, Suda T: A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 272: 22046-22042 (1997).
37. Paralkar VM, Nandedkar AK, Pointer RH, Kleinman HK, Reddi AH: Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem 265: 17281-17284 (1990).
38. Perreira RC, Rydziel S, Canalis E: Bone morphogenetic protein-4 regulates its own expression in cultured osteoblast. J Cell Physiol 182: 239-246 (2000).
39. Qu Q, Perala-Haepe M, Kapanen A, Dahllund J, Salo J, Vaananen HK, Harkonen P: Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22: 201-9 (1998).
40. Reddi AH: Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Nat Biotechnol 16: 247-252 (1998).
41. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I: Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228 (1994).
42. Rickard DJ, Hofbauer LC, Bonde SK, Gori F, Spelsberg TC, Riggs BL: Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 101: 413-422 (1998).
43. Robinson JA, Harris SA, Riggs BL, Spelsberg TC: Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138:2919-2927 (1997).
44. Rueger DC: Biochemistry of bone morphogenetic proteins. In: Bone morphogenetic proteins: from laboratory to clinical practice (Vukicevic S, Sampath TK, ed), Birkhauser Verlag, Basel-Boston-Berlin, 2002 (p. 1-18).
45. Sato M, Ochi T, Nakase T, Hirota S, Kitamura Y, Nomura S, Yasui N: Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res 14: 1084-1095 (1999).
46. Simic P, Buljan Culej J, Orlic I, Borovecki F, Spaventi R, Vukicevic S: Systemically administered BMP-6, unlike estradiol or PTH, restores trabecular bone of appendicular skeleton and induces de nuovo bone formation in the bone marrow of ovariectomized BMP-6 knock out mice. J Clin Invest (2006a, in press).
47. Simic P, Buljan Culej J, Draca N, Orlic I, Spaventi R and Vukicevic S: Systemically administered recombinant BMP-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption. J Biol Chem (2006b, in press).
48. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn FW, Kawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G: Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29: 323-330 (2001).
49. Stein GS, Lian JB: Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14: 424-442 (1993).
50. Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T: Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 140: 2125-2133 (1999).
51. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K: Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cell, MC3T3-E1. Biochem Biophys Res Commun 174: 96-101 (1991).
52. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K: Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269: 16985-16988 (1994).
53. van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Lowik CW. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199: 805-814 (2004).
54. van der Horst G, van Bezooijen RL, Deckers MML, Hoogendam J, Visser A, Lowik CWGM, Karperien M: Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 31: 661-669 (2002).
55. Vukicevic S, Luyten FP, Reddi AH: Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86:8793-8797 (1989).
56. Vukicevic S, Luyten FP, Reddi AH: Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun 166: 750-756 (1990).
57. Vukicevic S, Paralkar VM, Reddi AH: Extracellular matrix and bone morphogenetic proteins in cartilage and bone development and repair. Adv Mol Cell Biol 6:207-224 (1993).
58. Wada Y, Kataoka H, Yokose S, Ishizuya T, Miyazono K, Gao YH, Shibasaki Y, Yamaguchi A: Changes in osteoblast, phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 22: 479-485 (1998).
59. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT: Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 7: 101-110 (2002).
60. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S: Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem, Biophys Res Commun 220:366-371 (1996).
61. Yamaguchi A, Komori T, Suda T: Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393-411 (2000).
62. Yamaguchi M, Matsui T: Zinc enhancement of 17beta-estradiol's anabolic effect in osteoblastic MC3T3-E1 cells. Calcif Tissue Int 60: 527-532 (1997).
63. Yeh LC, Unda R, Lee JC: Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol 185: 87-97 (2000).
64. Yeh LC, Tsai AD, Lee JC: Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87: 292-304 (2002).